SAM
UTHR icon

Securian Asset Management’s United Therapeutics UTHR Stock Holding History

Securian Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Sell
3,130
-43
-1% -$24.2K 0.06% 221
2026
Q1 		$1.88M Buy
3,173
+35
+1% +$17.4K 0.07% 183
2025
Q4 		$1.53M Sell
3,138
-300
-9% -$140K 0.06% 209
2025
Q3 		$1.44M Hold
3,438
– – 0.04% 324
2025
Q2 		$988K Hold
3,438
– – 0.03% 432
2025
Q1 		$1.06M Hold
3,438
– – 0.03% 397
2024
Q4 		$1.21M Hold
3,438
– – 0.04% 368
2024
Q3 		$1.23M Sell
3,438
-100
-3% -$33.8K 0.04% 371
2024
Q2 		$1.13M Sell
3,538
-337
-9% -$89.2K 0.03% 381
2024
Q1 		$890K Sell
3,875
-100
-3% -$22.6K 0.03% 485
2023
Q4 		$874K Hold
3,975
– – 0.02% 473
2023
Q3 		$898K Sell
3,975
-255
-6% -$58.7K 0.03% 463
2023
Q2 		$934K Buy
4,230
+100
+2% +$22.1K 0.02% 490
2023
Q1 		$925K Sell
4,130
-100
-2% -$24.7K 0.02% 492
2022
Q4 		$1.18M Hold
4,230
– – 0.03% 419
2022
Q3 		$886K Buy
4,230
+100
+2% +$22.4K 0.03% 472
2022
Q2 		$973K Buy
4,130
+118
+3% +$24K 0.02% 515
2022
Q1 		$720K Hold
4,012
– – 0.01% 638
2021
Q4 		$867K Hold
4,012
– – 0.02% 606
2021
Q3 		$741K Sell
4,012
-100
-2% -$19.7K 0.02% 627
2021
Q2 		$738K Sell
4,112
-100
-2% -$19K 0.02% 642
2021
Q1 		$705K Hold
4,212
– – 0.02% 649
2020
Q4 		$639K Sell
4,212
-101
-2% -$13.3K 0.01% 651
2020
Q3 		$436K Sell
4,313
-136
-3% -$14.9K 0.01% 727
2020
Q2 		$538K Hold
4,449
– – 0.01% 665
2020
Q1 		$422K Hold
4,449
– – 0.01% 676
2019
Q4 		$392K Sell
4,449
-472
-10% -$41.5K 0.01% 845
2019
Q3 		$392K Sell
4,921
-277
-5% -$22.3K 0.01% 845
2019
Q2 		$406K Sell
5,198
-124
-2% -$11.6K 0.01% 852
2019
Q1 		$625K Hold
5,322
– – 0.01% 694
2018
Q4 		$580K Hold
5,322
– – 0.02% 679
2018
Q3 		$681K Sell
5,322
-100
-2% -$12.4K 0.02% 690
2018
Q2 		$613K Buy
5,422
+100
+2% +$11K 0.02% 714
2018
Q1 		$598K Hold
5,322
– – 0.02% 718
2017
Q4 		$787K Sell
5,322
-171
-3% -$21.7K 0.02% 645
2017
Q3 		$644K Sell
5,493
-164
-3% -$20.9K 0.02% 669
2017
Q2 		$734K Sell
5,657
-100
-2% -$12.5K 0.02% 614
2017
Q1 		$779K Buy
5,757
+466
+9% +$70.6K 0.02% 598
2016
Q4 		$759K Hold
5,291
– – 0.02% 590
2016
Q3 		$625K Sell
5,291
-113
-2% -$13.6K 0.02% 639
2016
Q2 		$572K Sell
5,404
-710
-12% -$79.2K 0.02% 648
2016
Q1 		$681K Buy
6,114
+133
+2% +$16.8K 0.02% 609
2015
Q4 		$937K Sell
5,981
-358
-6% -$52.1K 0.03% 496
2015
Q3 		$832K Sell
6,339
-190
-3% -$30.5K 0.03% 524
2015
Q2 		$1.14M Sell
6,529
-147
-2% -$26.4K 0.04% 441
2015
Q1 		$1.15M Hold
6,676
– – 0.03% 447
2014
Q4 		$864K Hold
6,676
– – 0.03% 530
2014
Q3 		$859K Buy
6,676
+493
+8% +$50.8K 0.03% 508
2014
Q2 		$547K Sell
6,183
-531
-8% -$51.1K 0.02% 705
2014
Q1 		$631K Hold
6,714
– – 0.02% 627
2013
Q4 		$759K Sell
6,714
-100
-1% -$9.02K 0.03% 547
2013
Q3 		$537K Sell
6,814
-100
-1% -$7.31K 0.02% 671
2013
Q2 		$455K Buy
+6,914
New +$445K 0.02% 692

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Securian Asset Management's UTHR Position: Q2 2026 in Review

Securian Asset Management reduced its United Therapeutics (UTHR) stake by 1.4% in Q2 2026, selling an estimated $24.2K and leaving 3,130 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #221.

Securian Asset Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.88M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Securian Asset Management held 3,130 shares of United Therapeutics worth $1.68M as of Q2 2026.
  • Securian Asset Management sold 43 United Therapeutics shares in Q2 2026, an estimated $24.2K.
  • United Therapeutics made up 0.06% of Securian Asset Management's portfolio in Q2 2026, its #221 holding.
  • Securian Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Securian Asset Management's United Therapeutics position peaked at $1.88M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.